Pharmos Corp. announced that as previously disclosed, on November 15, 2012, Eric Fangmann was designated as the acting President and acting Chief Financial Officer. Mr. Fangmann, age 43, has been the Chief Financial Officer for Lloyd I. Miller, III for approximately two years.

Prior to that time, Mr. Fangmann was an independent accounting and finance consultant who was principally engaged by either publicly traded or privately held entities to assist in independent analysis or agreed upon procedures.